PMC:7534206 / 7573-9662 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":214,"end":219},"obj":"Body_part"},{"id":"T10","span":{"begin":246,"end":250},"obj":"Body_part"},{"id":"T11","span":{"begin":276,"end":282},"obj":"Body_part"},{"id":"T12","span":{"begin":308,"end":313},"obj":"Body_part"},{"id":"T13","span":{"begin":865,"end":891},"obj":"Body_part"},{"id":"T14","span":{"begin":1115,"end":1120},"obj":"Body_part"},{"id":"T15","span":{"begin":1631,"end":1644},"obj":"Body_part"},{"id":"T16","span":{"begin":1631,"end":1642},"obj":"Body_part"},{"id":"T17","span":{"begin":1776,"end":1783},"obj":"Body_part"},{"id":"T18","span":{"begin":1823,"end":1846},"obj":"Body_part"},{"id":"T19","span":{"begin":1832,"end":1846},"obj":"Body_part"},{"id":"T20","span":{"begin":1840,"end":1846},"obj":"Body_part"},{"id":"T21","span":{"begin":1995,"end":2001},"obj":"Body_part"},{"id":"T22","span":{"begin":2009,"end":2045},"obj":"Body_part"},{"id":"T23","span":{"begin":2039,"end":2045},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma50087"},{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma24040"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma264829"},{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A18","pred":"fma_id","subj":"T18","obj":"http://purl.org/sig/ont/fma/fma3947"},{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma3939"},{"id":"A20","pred":"fma_id","subj":"T20","obj":"http://purl.org/sig/ont/fma/fma50720"},{"id":"A21","pred":"fma_id","subj":"T21","obj":"http://purl.org/sig/ont/fma/fma50720"},{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma50518"},{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma50720"}],"text":"Table 1. Demographics, procedure details, outcomes, and laboratory findings\nVariables Mean ± standard deviation; N (%)\nAge (years) 59.5 ± 16.0\nFemale gender 12 (55.5)\nComorbidities\n Hypertension 10 (45.0)\n Chronic heart disease 3 (13.6)\n Chronic lung disease 0 (0.0)\n Chronic kidney disease 1 (4.5)\n Chronic liver disease 0 (0.0)\n Diabetes mellitus 2 (9.1)\n Atrial fibrillation 3 (13.6)\n No comorbidities 12 (54.4)\nCOVID-19 characteristics\n Neurological insult as initial  manifestation of COVID-19 10 (45.5)\n Duration between COVID-19  symptoms and neurological  insults (days) 8.8 ± 4.4\n Fever 11 (50.0)\n Cough 11 (50.0)\n Pneumonia 9 (40.9)\nCerebrovascular insult\n Hemorrhagic stroke 3 (13.6)\n Ischemic stroke 19 (86.4)\nHemorrhagic stroke characteristics and outcomes\n 5.0 mm dissecting PICA aneurysm HH3, flow diversion\n 15 mm PCOM aneurysm HH4, clipped\n 1.4 mm anterior choroidal  artery aneurysm HH1, flow diversion\nIschemic stroke characteristics and outcomes\n Involved vessels 1.4 ± 0.7\n  ICA 3 (15.8)\n  M1 11 (57.9)\n  M2 1 (5.3)\n  Absent LVO 2 (10.5)\n  CVT 2 (10.5)\n NIHSS at admission 13.8 ± 8.0\n Onset to groin access (min) 272.2 ± 169.5\n Mechanical thrombectomy 16 (84.2)\n  General endotracheal anesthesia 13 (81.3)\n  MT technique\n   Contact aspiration 2 (12.5)\n   Stent retriever 1 (6.25)\n   Contact aspiration    + stent retriever 13 (81.3)\n  Procedure duration (min) 42.2 ± 36.3\n  Number of passes 2.1 ± 1.3\n  Rescue stenting 3 (18.8)\n  TICI 2B/3 16 (100)\n Symptomatic intracerebral  hemorrhage 3 (13.6)\nLaboratory findings\n CRP (mg/dl) 20.8 ± 37.9\n D-dimer (ng/dl) 3497.4 ± 6754.3\n Fibrinogen (mg/dl) 329.5 ± 235.4\n Interleukin-6 (pg/dl) 41.6 ± 62.0\nOutcomes at discharge\n mRS 3–6 11 (50)\n Mortality 8 (36.4)\nCOVID-19: coronavirus disease 2019; CRP: C-Reactive Protein; CVT: Cerebral Venous Thrombosis; ICA: Internal Carotid Artery; LVO: Large Vessel Occlusion; MT: mechanical thrombectomy; NIHSS: National Institute of Health Stroke Scale; PCOM: Posterior Cerebral Communicating Artery; PICA: Posterior Inferior Cerebellar Artery; TICI: thrombolysis in cerebral infarction."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T18","span":{"begin":214,"end":219},"obj":"Body_part"},{"id":"T19","span":{"begin":246,"end":250},"obj":"Body_part"},{"id":"T20","span":{"begin":276,"end":282},"obj":"Body_part"},{"id":"T21","span":{"begin":308,"end":313},"obj":"Body_part"},{"id":"T22","span":{"begin":865,"end":891},"obj":"Body_part"},{"id":"T23","span":{"begin":885,"end":891},"obj":"Body_part"},{"id":"T24","span":{"begin":976,"end":983},"obj":"Body_part"},{"id":"T25","span":{"begin":1823,"end":1846},"obj":"Body_part"},{"id":"T26","span":{"begin":1859,"end":1865},"obj":"Body_part"},{"id":"T27","span":{"begin":1949,"end":1954},"obj":"Body_part"},{"id":"T28","span":{"begin":1981,"end":2001},"obj":"Body_part"},{"id":"T29","span":{"begin":2009,"end":2045},"obj":"Body_part"},{"id":"T30","span":{"begin":2028,"end":2045},"obj":"Body_part"}],"attributes":[{"id":"A18","pred":"uberon_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A19","pred":"uberon_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A21","pred":"uberon_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A22","pred":"uberon_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/UBERON_0014696"},{"id":"A23","pred":"uberon_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"A24","pred":"uberon_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/UBERON_0000055"},{"id":"A25","pred":"uberon_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/UBERON_0001532"},{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0000055"},{"id":"A27","pred":"uberon_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"},{"id":"A28","pred":"uberon_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/UBERON_0006347"},{"id":"A29","pred":"uberon_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/UBERON_0009688"},{"id":"A30","pred":"uberon_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/UBERON_0003472"}],"text":"Table 1. Demographics, procedure details, outcomes, and laboratory findings\nVariables Mean ± standard deviation; N (%)\nAge (years) 59.5 ± 16.0\nFemale gender 12 (55.5)\nComorbidities\n Hypertension 10 (45.0)\n Chronic heart disease 3 (13.6)\n Chronic lung disease 0 (0.0)\n Chronic kidney disease 1 (4.5)\n Chronic liver disease 0 (0.0)\n Diabetes mellitus 2 (9.1)\n Atrial fibrillation 3 (13.6)\n No comorbidities 12 (54.4)\nCOVID-19 characteristics\n Neurological insult as initial  manifestation of COVID-19 10 (45.5)\n Duration between COVID-19  symptoms and neurological  insults (days) 8.8 ± 4.4\n Fever 11 (50.0)\n Cough 11 (50.0)\n Pneumonia 9 (40.9)\nCerebrovascular insult\n Hemorrhagic stroke 3 (13.6)\n Ischemic stroke 19 (86.4)\nHemorrhagic stroke characteristics and outcomes\n 5.0 mm dissecting PICA aneurysm HH3, flow diversion\n 15 mm PCOM aneurysm HH4, clipped\n 1.4 mm anterior choroidal  artery aneurysm HH1, flow diversion\nIschemic stroke characteristics and outcomes\n Involved vessels 1.4 ± 0.7\n  ICA 3 (15.8)\n  M1 11 (57.9)\n  M2 1 (5.3)\n  Absent LVO 2 (10.5)\n  CVT 2 (10.5)\n NIHSS at admission 13.8 ± 8.0\n Onset to groin access (min) 272.2 ± 169.5\n Mechanical thrombectomy 16 (84.2)\n  General endotracheal anesthesia 13 (81.3)\n  MT technique\n   Contact aspiration 2 (12.5)\n   Stent retriever 1 (6.25)\n   Contact aspiration    + stent retriever 13 (81.3)\n  Procedure duration (min) 42.2 ± 36.3\n  Number of passes 2.1 ± 1.3\n  Rescue stenting 3 (18.8)\n  TICI 2B/3 16 (100)\n Symptomatic intracerebral  hemorrhage 3 (13.6)\nLaboratory findings\n CRP (mg/dl) 20.8 ± 37.9\n D-dimer (ng/dl) 3497.4 ± 6754.3\n Fibrinogen (mg/dl) 329.5 ± 235.4\n Interleukin-6 (pg/dl) 41.6 ± 62.0\nOutcomes at discharge\n mRS 3–6 11 (50)\n Mortality 8 (36.4)\nCOVID-19: coronavirus disease 2019; CRP: C-Reactive Protein; CVT: Cerebral Venous Thrombosis; ICA: Internal Carotid Artery; LVO: Large Vessel Occlusion; MT: mechanical thrombectomy; NIHSS: National Institute of Health Stroke Scale; PCOM: Posterior Cerebral Communicating Artery; PICA: Posterior Inferior Cerebellar Artery; TICI: thrombolysis in cerebral infarction."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T87","span":{"begin":182,"end":194},"obj":"Disease"},{"id":"T88","span":{"begin":214,"end":227},"obj":"Disease"},{"id":"T89","span":{"begin":246,"end":258},"obj":"Disease"},{"id":"T90","span":{"begin":268,"end":290},"obj":"Disease"},{"id":"T91","span":{"begin":276,"end":290},"obj":"Disease"},{"id":"T93","span":{"begin":308,"end":321},"obj":"Disease"},{"id":"T94","span":{"begin":331,"end":348},"obj":"Disease"},{"id":"T95","span":{"begin":358,"end":377},"obj":"Disease"},{"id":"T96","span":{"begin":415,"end":423},"obj":"Disease"},{"id":"T97","span":{"begin":490,"end":498},"obj":"Disease"},{"id":"T98","span":{"begin":527,"end":535},"obj":"Disease"},{"id":"T99","span":{"begin":624,"end":633},"obj":"Disease"},{"id":"T100","span":{"begin":679,"end":685},"obj":"Disease"},{"id":"T102","span":{"begin":705,"end":711},"obj":"Disease"},{"id":"T104","span":{"begin":734,"end":740},"obj":"Disease"},{"id":"T106","span":{"begin":803,"end":806},"obj":"Disease"},{"id":"T107","span":{"begin":844,"end":847},"obj":"Disease"},{"id":"T108","span":{"begin":901,"end":904},"obj":"Disease"},{"id":"T109","span":{"begin":930,"end":936},"obj":"Disease"},{"id":"T111","span":{"begin":1061,"end":1064},"obj":"Disease"},{"id":"T112","span":{"begin":1483,"end":1508},"obj":"Disease"},{"id":"T113","span":{"begin":1724,"end":1732},"obj":"Disease"},{"id":"T114","span":{"begin":1734,"end":1758},"obj":"Disease"},{"id":"T115","span":{"begin":1785,"end":1788},"obj":"Disease"},{"id":"T116","span":{"begin":1799,"end":1816},"obj":"Disease"},{"id":"T117","span":{"begin":1806,"end":1816},"obj":"Disease"},{"id":"T118","span":{"begin":1942,"end":1948},"obj":"Disease"},{"id":"T120","span":{"begin":2069,"end":2088},"obj":"Disease"}],"attributes":[{"id":"A87","pred":"mondo_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A88","pred":"mondo_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/MONDO_0005267"},{"id":"A89","pred":"mondo_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A90","pred":"mondo_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A91","pred":"mondo_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/MONDO_0001343"},{"id":"A92","pred":"mondo_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A93","pred":"mondo_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/MONDO_0005154"},{"id":"A94","pred":"mondo_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A95","pred":"mondo_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/MONDO_0004981"},{"id":"A96","pred":"mondo_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A99","pred":"mondo_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A100","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A101","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A102","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A103","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A104","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A105","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A106","pred":"mondo_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/MONDO_0009482"},{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0012528"},{"id":"A108","pred":"mondo_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/MONDO_0010635"},{"id":"A109","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A110","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0008652"},{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0013792"},{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A114","pred":"mondo_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0008652"},{"id":"A116","pred":"mondo_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/MONDO_0008559"},{"id":"A117","pred":"mondo_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"},{"id":"A118","pred":"mondo_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A119","pred":"mondo_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0002679"},{"id":"A121","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A122","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A123","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0020671"}],"text":"Table 1. Demographics, procedure details, outcomes, and laboratory findings\nVariables Mean ± standard deviation; N (%)\nAge (years) 59.5 ± 16.0\nFemale gender 12 (55.5)\nComorbidities\n Hypertension 10 (45.0)\n Chronic heart disease 3 (13.6)\n Chronic lung disease 0 (0.0)\n Chronic kidney disease 1 (4.5)\n Chronic liver disease 0 (0.0)\n Diabetes mellitus 2 (9.1)\n Atrial fibrillation 3 (13.6)\n No comorbidities 12 (54.4)\nCOVID-19 characteristics\n Neurological insult as initial  manifestation of COVID-19 10 (45.5)\n Duration between COVID-19  symptoms and neurological  insults (days) 8.8 ± 4.4\n Fever 11 (50.0)\n Cough 11 (50.0)\n Pneumonia 9 (40.9)\nCerebrovascular insult\n Hemorrhagic stroke 3 (13.6)\n Ischemic stroke 19 (86.4)\nHemorrhagic stroke characteristics and outcomes\n 5.0 mm dissecting PICA aneurysm HH3, flow diversion\n 15 mm PCOM aneurysm HH4, clipped\n 1.4 mm anterior choroidal  artery aneurysm HH1, flow diversion\nIschemic stroke characteristics and outcomes\n Involved vessels 1.4 ± 0.7\n  ICA 3 (15.8)\n  M1 11 (57.9)\n  M2 1 (5.3)\n  Absent LVO 2 (10.5)\n  CVT 2 (10.5)\n NIHSS at admission 13.8 ± 8.0\n Onset to groin access (min) 272.2 ± 169.5\n Mechanical thrombectomy 16 (84.2)\n  General endotracheal anesthesia 13 (81.3)\n  MT technique\n   Contact aspiration 2 (12.5)\n   Stent retriever 1 (6.25)\n   Contact aspiration    + stent retriever 13 (81.3)\n  Procedure duration (min) 42.2 ± 36.3\n  Number of passes 2.1 ± 1.3\n  Rescue stenting 3 (18.8)\n  TICI 2B/3 16 (100)\n Symptomatic intracerebral  hemorrhage 3 (13.6)\nLaboratory findings\n CRP (mg/dl) 20.8 ± 37.9\n D-dimer (ng/dl) 3497.4 ± 6754.3\n Fibrinogen (mg/dl) 329.5 ± 235.4\n Interleukin-6 (pg/dl) 41.6 ± 62.0\nOutcomes at discharge\n mRS 3–6 11 (50)\n Mortality 8 (36.4)\nCOVID-19: coronavirus disease 2019; CRP: C-Reactive Protein; CVT: Cerebral Venous Thrombosis; ICA: Internal Carotid Artery; LVO: Large Vessel Occlusion; MT: mechanical thrombectomy; NIHSS: National Institute of Health Stroke Scale; PCOM: Posterior Cerebral Communicating Artery; PICA: Posterior Inferior Cerebellar Artery; TICI: thrombolysis in cerebral infarction."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T67","span":{"begin":143,"end":149},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T68","span":{"begin":214,"end":219},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T69","span":{"begin":214,"end":219},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T70","span":{"begin":214,"end":219},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T71","span":{"begin":214,"end":219},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T72","span":{"begin":246,"end":250},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T73","span":{"begin":246,"end":250},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T74","span":{"begin":276,"end":282},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T75","span":{"begin":276,"end":282},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T76","span":{"begin":276,"end":282},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T77","span":{"begin":308,"end":313},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T78","span":{"begin":308,"end":313},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T79","span":{"begin":596,"end":598},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T80","span":{"begin":613,"end":615},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T81","span":{"begin":885,"end":891},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T82","span":{"begin":885,"end":891},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"},{"id":"T83","span":{"begin":976,"end":983},"obj":"http://purl.obolibrary.org/obo/UBERON_0000055"},{"id":"T84","span":{"begin":1011,"end":1016},"obj":"http://purl.obolibrary.org/obo/CLO_0007438"},{"id":"T85","span":{"begin":1115,"end":1120},"obj":"http://www.ebi.ac.uk/efo/EFO_0001397"},{"id":"T86","span":{"begin":1631,"end":1644},"obj":"http://purl.obolibrary.org/obo/PR_000001393"},{"id":"T87","span":{"begin":1646,"end":1648},"obj":"http://purl.obolibrary.org/obo/CLO_0008426"},{"id":"T88","span":{"begin":1692,"end":1695},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T89","span":{"begin":1696,"end":1698},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T90","span":{"begin":1823,"end":1846},"obj":"http://www.ebi.ac.uk/efo/EFO_0000818"},{"id":"T91","span":{"begin":1859,"end":1865},"obj":"http://purl.obolibrary.org/obo/UBERON_0000055"},{"id":"T92","span":{"begin":1962,"end":1971},"obj":"http://purl.obolibrary.org/obo/UBERON_0001353"},{"id":"T93","span":{"begin":1995,"end":2001},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T94","span":{"begin":1995,"end":2001},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"},{"id":"T95","span":{"begin":2009,"end":2018},"obj":"http://purl.obolibrary.org/obo/UBERON_0001353"},{"id":"T96","span":{"begin":2039,"end":2045},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T97","span":{"begin":2039,"end":2045},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"}],"text":"Table 1. Demographics, procedure details, outcomes, and laboratory findings\nVariables Mean ± standard deviation; N (%)\nAge (years) 59.5 ± 16.0\nFemale gender 12 (55.5)\nComorbidities\n Hypertension 10 (45.0)\n Chronic heart disease 3 (13.6)\n Chronic lung disease 0 (0.0)\n Chronic kidney disease 1 (4.5)\n Chronic liver disease 0 (0.0)\n Diabetes mellitus 2 (9.1)\n Atrial fibrillation 3 (13.6)\n No comorbidities 12 (54.4)\nCOVID-19 characteristics\n Neurological insult as initial  manifestation of COVID-19 10 (45.5)\n Duration between COVID-19  symptoms and neurological  insults (days) 8.8 ± 4.4\n Fever 11 (50.0)\n Cough 11 (50.0)\n Pneumonia 9 (40.9)\nCerebrovascular insult\n Hemorrhagic stroke 3 (13.6)\n Ischemic stroke 19 (86.4)\nHemorrhagic stroke characteristics and outcomes\n 5.0 mm dissecting PICA aneurysm HH3, flow diversion\n 15 mm PCOM aneurysm HH4, clipped\n 1.4 mm anterior choroidal  artery aneurysm HH1, flow diversion\nIschemic stroke characteristics and outcomes\n Involved vessels 1.4 ± 0.7\n  ICA 3 (15.8)\n  M1 11 (57.9)\n  M2 1 (5.3)\n  Absent LVO 2 (10.5)\n  CVT 2 (10.5)\n NIHSS at admission 13.8 ± 8.0\n Onset to groin access (min) 272.2 ± 169.5\n Mechanical thrombectomy 16 (84.2)\n  General endotracheal anesthesia 13 (81.3)\n  MT technique\n   Contact aspiration 2 (12.5)\n   Stent retriever 1 (6.25)\n   Contact aspiration    + stent retriever 13 (81.3)\n  Procedure duration (min) 42.2 ± 36.3\n  Number of passes 2.1 ± 1.3\n  Rescue stenting 3 (18.8)\n  TICI 2B/3 16 (100)\n Symptomatic intracerebral  hemorrhage 3 (13.6)\nLaboratory findings\n CRP (mg/dl) 20.8 ± 37.9\n D-dimer (ng/dl) 3497.4 ± 6754.3\n Fibrinogen (mg/dl) 329.5 ± 235.4\n Interleukin-6 (pg/dl) 41.6 ± 62.0\nOutcomes at discharge\n mRS 3–6 11 (50)\n Mortality 8 (36.4)\nCOVID-19: coronavirus disease 2019; CRP: C-Reactive Protein; CVT: Cerebral Venous Thrombosis; ICA: Internal Carotid Artery; LVO: Large Vessel Occlusion; MT: mechanical thrombectomy; NIHSS: National Institute of Health Stroke Scale; PCOM: Posterior Cerebral Communicating Artery; PICA: Posterior Inferior Cerebellar Artery; TICI: thrombolysis in cerebral infarction."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":996,"end":999},"obj":"Chemical"},{"id":"T8","span":{"begin":1011,"end":1013},"obj":"Chemical"},{"id":"T12","span":{"begin":1026,"end":1028},"obj":"Chemical"},{"id":"T14","span":{"begin":1229,"end":1231},"obj":"Chemical"},{"id":"T15","span":{"begin":1776,"end":1783},"obj":"Chemical"},{"id":"T16","span":{"begin":1818,"end":1821},"obj":"Chemical"},{"id":"T17","span":{"begin":1877,"end":1879},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_29202"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_51079"},{"id":"A9","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_139019"},{"id":"A10","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_140152"},{"id":"A11","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_34826"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_34827"},{"id":"A13","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_51112"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_73614"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_16541"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_29202"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_73614"}],"text":"Table 1. Demographics, procedure details, outcomes, and laboratory findings\nVariables Mean ± standard deviation; N (%)\nAge (years) 59.5 ± 16.0\nFemale gender 12 (55.5)\nComorbidities\n Hypertension 10 (45.0)\n Chronic heart disease 3 (13.6)\n Chronic lung disease 0 (0.0)\n Chronic kidney disease 1 (4.5)\n Chronic liver disease 0 (0.0)\n Diabetes mellitus 2 (9.1)\n Atrial fibrillation 3 (13.6)\n No comorbidities 12 (54.4)\nCOVID-19 characteristics\n Neurological insult as initial  manifestation of COVID-19 10 (45.5)\n Duration between COVID-19  symptoms and neurological  insults (days) 8.8 ± 4.4\n Fever 11 (50.0)\n Cough 11 (50.0)\n Pneumonia 9 (40.9)\nCerebrovascular insult\n Hemorrhagic stroke 3 (13.6)\n Ischemic stroke 19 (86.4)\nHemorrhagic stroke characteristics and outcomes\n 5.0 mm dissecting PICA aneurysm HH3, flow diversion\n 15 mm PCOM aneurysm HH4, clipped\n 1.4 mm anterior choroidal  artery aneurysm HH1, flow diversion\nIschemic stroke characteristics and outcomes\n Involved vessels 1.4 ± 0.7\n  ICA 3 (15.8)\n  M1 11 (57.9)\n  M2 1 (5.3)\n  Absent LVO 2 (10.5)\n  CVT 2 (10.5)\n NIHSS at admission 13.8 ± 8.0\n Onset to groin access (min) 272.2 ± 169.5\n Mechanical thrombectomy 16 (84.2)\n  General endotracheal anesthesia 13 (81.3)\n  MT technique\n   Contact aspiration 2 (12.5)\n   Stent retriever 1 (6.25)\n   Contact aspiration    + stent retriever 13 (81.3)\n  Procedure duration (min) 42.2 ± 36.3\n  Number of passes 2.1 ± 1.3\n  Rescue stenting 3 (18.8)\n  TICI 2B/3 16 (100)\n Symptomatic intracerebral  hemorrhage 3 (13.6)\nLaboratory findings\n CRP (mg/dl) 20.8 ± 37.9\n D-dimer (ng/dl) 3497.4 ± 6754.3\n Fibrinogen (mg/dl) 329.5 ± 235.4\n Interleukin-6 (pg/dl) 41.6 ± 62.0\nOutcomes at discharge\n mRS 3–6 11 (50)\n Mortality 8 (36.4)\nCOVID-19: coronavirus disease 2019; CRP: C-Reactive Protein; CVT: Cerebral Venous Thrombosis; ICA: Internal Carotid Artery; LVO: Large Vessel Occlusion; MT: mechanical thrombectomy; NIHSS: National Institute of Health Stroke Scale; PCOM: Posterior Cerebral Communicating Artery; PICA: Posterior Inferior Cerebellar Artery; TICI: thrombolysis in cerebral infarction."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T31","span":{"begin":182,"end":194},"obj":"Phenotype"},{"id":"T32","span":{"begin":238,"end":258},"obj":"Phenotype"},{"id":"T33","span":{"begin":268,"end":290},"obj":"Phenotype"},{"id":"T34","span":{"begin":308,"end":321},"obj":"Phenotype"},{"id":"T35","span":{"begin":331,"end":348},"obj":"Phenotype"},{"id":"T36","span":{"begin":358,"end":377},"obj":"Phenotype"},{"id":"T37","span":{"begin":590,"end":595},"obj":"Phenotype"},{"id":"T38","span":{"begin":607,"end":612},"obj":"Phenotype"},{"id":"T39","span":{"begin":624,"end":633},"obj":"Phenotype"},{"id":"T40","span":{"begin":667,"end":685},"obj":"Phenotype"},{"id":"T41","span":{"begin":696,"end":711},"obj":"Phenotype"},{"id":"T42","span":{"begin":722,"end":740},"obj":"Phenotype"},{"id":"T43","span":{"begin":789,"end":793},"obj":"Phenotype"},{"id":"T44","span":{"begin":794,"end":802},"obj":"Phenotype"},{"id":"T45","span":{"begin":835,"end":843},"obj":"Phenotype"},{"id":"T46","span":{"begin":892,"end":900},"obj":"Phenotype"},{"id":"T47","span":{"begin":921,"end":936},"obj":"Phenotype"},{"id":"T48","span":{"begin":1253,"end":1263},"obj":"Phenotype"},{"id":"T49","span":{"begin":1312,"end":1322},"obj":"Phenotype"},{"id":"T50","span":{"begin":1483,"end":1508},"obj":"Phenotype"},{"id":"T51","span":{"begin":1790,"end":1816},"obj":"Phenotype"},{"id":"T52","span":{"begin":1942,"end":1948},"obj":"Phenotype"},{"id":"T53","span":{"begin":2003,"end":2007},"obj":"Phenotype"}],"attributes":[{"id":"A31","pred":"hp_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0006528"},{"id":"A33","pred":"hp_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/HP_0012622"},{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0001392"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0000819"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0005110"},{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A38","pred":"hp_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A40","pred":"hp_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/HP_0001342"},{"id":"A41","pred":"hp_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/HP_0002140"},{"id":"A42","pred":"hp_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/HP_0001342"},{"id":"A43","pred":"hp_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/HP_0011856"},{"id":"A44","pred":"hp_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/HP_0002617"},{"id":"A45","pred":"hp_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/HP_0002617"},{"id":"A46","pred":"hp_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/HP_0002617"},{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0002140"},{"id":"A48","pred":"hp_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/HP_0002835"},{"id":"A49","pred":"hp_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/HP_0002835"},{"id":"A50","pred":"hp_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/HP_0001342"},{"id":"A51","pred":"hp_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/HP_0005305"},{"id":"A52","pred":"hp_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/HP_0001297"},{"id":"A53","pred":"hp_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/HP_0011856"}],"text":"Table 1. Demographics, procedure details, outcomes, and laboratory findings\nVariables Mean ± standard deviation; N (%)\nAge (years) 59.5 ± 16.0\nFemale gender 12 (55.5)\nComorbidities\n Hypertension 10 (45.0)\n Chronic heart disease 3 (13.6)\n Chronic lung disease 0 (0.0)\n Chronic kidney disease 1 (4.5)\n Chronic liver disease 0 (0.0)\n Diabetes mellitus 2 (9.1)\n Atrial fibrillation 3 (13.6)\n No comorbidities 12 (54.4)\nCOVID-19 characteristics\n Neurological insult as initial  manifestation of COVID-19 10 (45.5)\n Duration between COVID-19  symptoms and neurological  insults (days) 8.8 ± 4.4\n Fever 11 (50.0)\n Cough 11 (50.0)\n Pneumonia 9 (40.9)\nCerebrovascular insult\n Hemorrhagic stroke 3 (13.6)\n Ischemic stroke 19 (86.4)\nHemorrhagic stroke characteristics and outcomes\n 5.0 mm dissecting PICA aneurysm HH3, flow diversion\n 15 mm PCOM aneurysm HH4, clipped\n 1.4 mm anterior choroidal  artery aneurysm HH1, flow diversion\nIschemic stroke characteristics and outcomes\n Involved vessels 1.4 ± 0.7\n  ICA 3 (15.8)\n  M1 11 (57.9)\n  M2 1 (5.3)\n  Absent LVO 2 (10.5)\n  CVT 2 (10.5)\n NIHSS at admission 13.8 ± 8.0\n Onset to groin access (min) 272.2 ± 169.5\n Mechanical thrombectomy 16 (84.2)\n  General endotracheal anesthesia 13 (81.3)\n  MT technique\n   Contact aspiration 2 (12.5)\n   Stent retriever 1 (6.25)\n   Contact aspiration    + stent retriever 13 (81.3)\n  Procedure duration (min) 42.2 ± 36.3\n  Number of passes 2.1 ± 1.3\n  Rescue stenting 3 (18.8)\n  TICI 2B/3 16 (100)\n Symptomatic intracerebral  hemorrhage 3 (13.6)\nLaboratory findings\n CRP (mg/dl) 20.8 ± 37.9\n D-dimer (ng/dl) 3497.4 ± 6754.3\n Fibrinogen (mg/dl) 329.5 ± 235.4\n Interleukin-6 (pg/dl) 41.6 ± 62.0\nOutcomes at discharge\n mRS 3–6 11 (50)\n Mortality 8 (36.4)\nCOVID-19: coronavirus disease 2019; CRP: C-Reactive Protein; CVT: Cerebral Venous Thrombosis; ICA: Internal Carotid Artery; LVO: Large Vessel Occlusion; MT: mechanical thrombectomy; NIHSS: National Institute of Health Stroke Scale; PCOM: Posterior Cerebral Communicating Artery; PICA: Posterior Inferior Cerebellar Artery; TICI: thrombolysis in cerebral infarction."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":803,"end":806},"obj":"GlycoEpitope"},{"id":"T2","span":{"begin":844,"end":847},"obj":"GlycoEpitope"},{"id":"T3","span":{"begin":901,"end":904},"obj":"GlycoEpitope"}],"attributes":[{"id":"A1","pred":"glyco_epitope_db_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/AN0605"},{"id":"A2","pred":"glyco_epitope_db_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/AN0607"},{"id":"A3","pred":"glyco_epitope_db_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/AN0604"}],"text":"Table 1. Demographics, procedure details, outcomes, and laboratory findings\nVariables Mean ± standard deviation; N (%)\nAge (years) 59.5 ± 16.0\nFemale gender 12 (55.5)\nComorbidities\n Hypertension 10 (45.0)\n Chronic heart disease 3 (13.6)\n Chronic lung disease 0 (0.0)\n Chronic kidney disease 1 (4.5)\n Chronic liver disease 0 (0.0)\n Diabetes mellitus 2 (9.1)\n Atrial fibrillation 3 (13.6)\n No comorbidities 12 (54.4)\nCOVID-19 characteristics\n Neurological insult as initial  manifestation of COVID-19 10 (45.5)\n Duration between COVID-19  symptoms and neurological  insults (days) 8.8 ± 4.4\n Fever 11 (50.0)\n Cough 11 (50.0)\n Pneumonia 9 (40.9)\nCerebrovascular insult\n Hemorrhagic stroke 3 (13.6)\n Ischemic stroke 19 (86.4)\nHemorrhagic stroke characteristics and outcomes\n 5.0 mm dissecting PICA aneurysm HH3, flow diversion\n 15 mm PCOM aneurysm HH4, clipped\n 1.4 mm anterior choroidal  artery aneurysm HH1, flow diversion\nIschemic stroke characteristics and outcomes\n Involved vessels 1.4 ± 0.7\n  ICA 3 (15.8)\n  M1 11 (57.9)\n  M2 1 (5.3)\n  Absent LVO 2 (10.5)\n  CVT 2 (10.5)\n NIHSS at admission 13.8 ± 8.0\n Onset to groin access (min) 272.2 ± 169.5\n Mechanical thrombectomy 16 (84.2)\n  General endotracheal anesthesia 13 (81.3)\n  MT technique\n   Contact aspiration 2 (12.5)\n   Stent retriever 1 (6.25)\n   Contact aspiration    + stent retriever 13 (81.3)\n  Procedure duration (min) 42.2 ± 36.3\n  Number of passes 2.1 ± 1.3\n  Rescue stenting 3 (18.8)\n  TICI 2B/3 16 (100)\n Symptomatic intracerebral  hemorrhage 3 (13.6)\nLaboratory findings\n CRP (mg/dl) 20.8 ± 37.9\n D-dimer (ng/dl) 3497.4 ± 6754.3\n Fibrinogen (mg/dl) 329.5 ± 235.4\n Interleukin-6 (pg/dl) 41.6 ± 62.0\nOutcomes at discharge\n mRS 3–6 11 (50)\n Mortality 8 (36.4)\nCOVID-19: coronavirus disease 2019; CRP: C-Reactive Protein; CVT: Cerebral Venous Thrombosis; ICA: Internal Carotid Artery; LVO: Large Vessel Occlusion; MT: mechanical thrombectomy; NIHSS: National Institute of Health Stroke Scale; PCOM: Posterior Cerebral Communicating Artery; PICA: Posterior Inferior Cerebellar Artery; TICI: thrombolysis in cerebral infarction."}

{"project":"LitCovid-sentences","denotations":[{"id":"T59","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"T60","span":{"begin":9,"end":75},"obj":"Sentence"},{"id":"T61","span":{"begin":76,"end":118},"obj":"Sentence"},{"id":"T62","span":{"begin":119,"end":142},"obj":"Sentence"},{"id":"T63","span":{"begin":143,"end":166},"obj":"Sentence"},{"id":"T64","span":{"begin":167,"end":180},"obj":"Sentence"},{"id":"T65","span":{"begin":181,"end":204},"obj":"Sentence"},{"id":"T66","span":{"begin":205,"end":236},"obj":"Sentence"},{"id":"T67","span":{"begin":237,"end":266},"obj":"Sentence"},{"id":"T68","span":{"begin":267,"end":298},"obj":"Sentence"},{"id":"T69","span":{"begin":299,"end":329},"obj":"Sentence"},{"id":"T70","span":{"begin":330,"end":356},"obj":"Sentence"},{"id":"T71","span":{"begin":357,"end":386},"obj":"Sentence"},{"id":"T72","span":{"begin":387,"end":414},"obj":"Sentence"},{"id":"T73","span":{"begin":415,"end":439},"obj":"Sentence"},{"id":"T74","span":{"begin":440,"end":508},"obj":"Sentence"},{"id":"T75","span":{"begin":509,"end":588},"obj":"Sentence"},{"id":"T76","span":{"begin":589,"end":605},"obj":"Sentence"},{"id":"T77","span":{"begin":606,"end":622},"obj":"Sentence"},{"id":"T78","span":{"begin":623,"end":642},"obj":"Sentence"},{"id":"T79","span":{"begin":643,"end":665},"obj":"Sentence"},{"id":"T80","span":{"begin":666,"end":694},"obj":"Sentence"},{"id":"T81","span":{"begin":695,"end":721},"obj":"Sentence"},{"id":"T82","span":{"begin":722,"end":769},"obj":"Sentence"},{"id":"T83","span":{"begin":770,"end":822},"obj":"Sentence"},{"id":"T84","span":{"begin":823,"end":856},"obj":"Sentence"},{"id":"T85","span":{"begin":857,"end":920},"obj":"Sentence"},{"id":"T86","span":{"begin":921,"end":965},"obj":"Sentence"},{"id":"T87","span":{"begin":966,"end":993},"obj":"Sentence"},{"id":"T88","span":{"begin":994,"end":1008},"obj":"Sentence"},{"id":"T89","span":{"begin":1009,"end":1023},"obj":"Sentence"},{"id":"T90","span":{"begin":1024,"end":1036},"obj":"Sentence"},{"id":"T91","span":{"begin":1037,"end":1058},"obj":"Sentence"},{"id":"T92","span":{"begin":1059,"end":1073},"obj":"Sentence"},{"id":"T93","span":{"begin":1074,"end":1104},"obj":"Sentence"},{"id":"T94","span":{"begin":1105,"end":1147},"obj":"Sentence"},{"id":"T95","span":{"begin":1148,"end":1182},"obj":"Sentence"},{"id":"T96","span":{"begin":1183,"end":1226},"obj":"Sentence"},{"id":"T97","span":{"begin":1227,"end":1241},"obj":"Sentence"},{"id":"T98","span":{"begin":1242,"end":1272},"obj":"Sentence"},{"id":"T99","span":{"begin":1273,"end":1300},"obj":"Sentence"},{"id":"T100","span":{"begin":1301,"end":1353},"obj":"Sentence"},{"id":"T101","span":{"begin":1354,"end":1392},"obj":"Sentence"},{"id":"T102","span":{"begin":1393,"end":1421},"obj":"Sentence"},{"id":"T103","span":{"begin":1422,"end":1448},"obj":"Sentence"},{"id":"T104","span":{"begin":1449,"end":1469},"obj":"Sentence"},{"id":"T105","span":{"begin":1470,"end":1517},"obj":"Sentence"},{"id":"T106","span":{"begin":1518,"end":1537},"obj":"Sentence"},{"id":"T107","span":{"begin":1538,"end":1562},"obj":"Sentence"},{"id":"T108","span":{"begin":1563,"end":1595},"obj":"Sentence"},{"id":"T109","span":{"begin":1596,"end":1629},"obj":"Sentence"},{"id":"T110","span":{"begin":1630,"end":1664},"obj":"Sentence"},{"id":"T111","span":{"begin":1665,"end":1686},"obj":"Sentence"},{"id":"T112","span":{"begin":1687,"end":1703},"obj":"Sentence"},{"id":"T113","span":{"begin":1704,"end":1723},"obj":"Sentence"},{"id":"T114","span":{"begin":1724,"end":1789},"obj":"Sentence"},{"id":"T115","span":{"begin":1790,"end":1822},"obj":"Sentence"},{"id":"T116","span":{"begin":1823,"end":1852},"obj":"Sentence"},{"id":"T117","span":{"begin":1853,"end":1912},"obj":"Sentence"},{"id":"T118","span":{"begin":1913,"end":1961},"obj":"Sentence"},{"id":"T119","span":{"begin":1962,"end":2008},"obj":"Sentence"},{"id":"T120","span":{"begin":2009,"end":2089},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 1. Demographics, procedure details, outcomes, and laboratory findings\nVariables Mean ± standard deviation; N (%)\nAge (years) 59.5 ± 16.0\nFemale gender 12 (55.5)\nComorbidities\n Hypertension 10 (45.0)\n Chronic heart disease 3 (13.6)\n Chronic lung disease 0 (0.0)\n Chronic kidney disease 1 (4.5)\n Chronic liver disease 0 (0.0)\n Diabetes mellitus 2 (9.1)\n Atrial fibrillation 3 (13.6)\n No comorbidities 12 (54.4)\nCOVID-19 characteristics\n Neurological insult as initial  manifestation of COVID-19 10 (45.5)\n Duration between COVID-19  symptoms and neurological  insults (days) 8.8 ± 4.4\n Fever 11 (50.0)\n Cough 11 (50.0)\n Pneumonia 9 (40.9)\nCerebrovascular insult\n Hemorrhagic stroke 3 (13.6)\n Ischemic stroke 19 (86.4)\nHemorrhagic stroke characteristics and outcomes\n 5.0 mm dissecting PICA aneurysm HH3, flow diversion\n 15 mm PCOM aneurysm HH4, clipped\n 1.4 mm anterior choroidal  artery aneurysm HH1, flow diversion\nIschemic stroke characteristics and outcomes\n Involved vessels 1.4 ± 0.7\n  ICA 3 (15.8)\n  M1 11 (57.9)\n  M2 1 (5.3)\n  Absent LVO 2 (10.5)\n  CVT 2 (10.5)\n NIHSS at admission 13.8 ± 8.0\n Onset to groin access (min) 272.2 ± 169.5\n Mechanical thrombectomy 16 (84.2)\n  General endotracheal anesthesia 13 (81.3)\n  MT technique\n   Contact aspiration 2 (12.5)\n   Stent retriever 1 (6.25)\n   Contact aspiration    + stent retriever 13 (81.3)\n  Procedure duration (min) 42.2 ± 36.3\n  Number of passes 2.1 ± 1.3\n  Rescue stenting 3 (18.8)\n  TICI 2B/3 16 (100)\n Symptomatic intracerebral  hemorrhage 3 (13.6)\nLaboratory findings\n CRP (mg/dl) 20.8 ± 37.9\n D-dimer (ng/dl) 3497.4 ± 6754.3\n Fibrinogen (mg/dl) 329.5 ± 235.4\n Interleukin-6 (pg/dl) 41.6 ± 62.0\nOutcomes at discharge\n mRS 3–6 11 (50)\n Mortality 8 (36.4)\nCOVID-19: coronavirus disease 2019; CRP: C-Reactive Protein; CVT: Cerebral Venous Thrombosis; ICA: Internal Carotid Artery; LVO: Large Vessel Occlusion; MT: mechanical thrombectomy; NIHSS: National Institute of Health Stroke Scale; PCOM: Posterior Cerebral Communicating Artery; PICA: Posterior Inferior Cerebellar Artery; TICI: thrombolysis in cerebral infarction."}

{"project":"LitCovid-PubTator","denotations":[{"id":"187","span":{"begin":1539,"end":1542},"obj":"Gene"},{"id":"188","span":{"begin":1631,"end":1644},"obj":"Gene"},{"id":"189","span":{"begin":1597,"end":1607},"obj":"Gene"},{"id":"190","span":{"begin":182,"end":194},"obj":"Disease"},{"id":"191","span":{"begin":214,"end":227},"obj":"Disease"},{"id":"192","span":{"begin":246,"end":258},"obj":"Disease"},{"id":"193","span":{"begin":268,"end":290},"obj":"Disease"},{"id":"194","span":{"begin":308,"end":321},"obj":"Disease"},{"id":"195","span":{"begin":331,"end":348},"obj":"Disease"},{"id":"196","span":{"begin":358,"end":377},"obj":"Disease"},{"id":"197","span":{"begin":415,"end":423},"obj":"Disease"},{"id":"198","span":{"begin":490,"end":498},"obj":"Disease"},{"id":"199","span":{"begin":527,"end":535},"obj":"Disease"},{"id":"200","span":{"begin":590,"end":595},"obj":"Disease"},{"id":"201","span":{"begin":607,"end":612},"obj":"Disease"},{"id":"202","span":{"begin":624,"end":633},"obj":"Disease"},{"id":"203","span":{"begin":643,"end":685},"obj":"Disease"},{"id":"204","span":{"begin":705,"end":714},"obj":"Disease"},{"id":"205","span":{"begin":734,"end":740},"obj":"Disease"},{"id":"206","span":{"begin":794,"end":802},"obj":"Disease"},{"id":"207","span":{"begin":835,"end":843},"obj":"Disease"},{"id":"208","span":{"begin":874,"end":900},"obj":"Disease"},{"id":"209","span":{"begin":921,"end":936},"obj":"Disease"},{"id":"210","span":{"begin":1483,"end":1508},"obj":"Disease"},{"id":"211","span":{"begin":1705,"end":1714},"obj":"Disease"},{"id":"219","span":{"begin":1765,"end":1783},"obj":"Gene"},{"id":"220","span":{"begin":1760,"end":1763},"obj":"Gene"},{"id":"221","span":{"begin":1734,"end":1758},"obj":"Disease"},{"id":"222","span":{"begin":1790,"end":1816},"obj":"Disease"},{"id":"223","span":{"begin":1859,"end":1875},"obj":"Disease"},{"id":"224","span":{"begin":1942,"end":1948},"obj":"Disease"},{"id":"225","span":{"begin":2053,"end":2088},"obj":"Disease"}],"attributes":[{"id":"A187","pred":"tao:has_database_id","subj":"187","obj":"Gene:1401"},{"id":"A188","pred":"tao:has_database_id","subj":"188","obj":"Gene:3569"},{"id":"A189","pred":"tao:has_database_id","subj":"189","obj":"Gene:2244"},{"id":"A190","pred":"tao:has_database_id","subj":"190","obj":"MESH:D006973"},{"id":"A191","pred":"tao:has_database_id","subj":"191","obj":"MESH:D006331"},{"id":"A192","pred":"tao:has_database_id","subj":"192","obj":"MESH:D008171"},{"id":"A193","pred":"tao:has_database_id","subj":"193","obj":"MESH:D051436"},{"id":"A194","pred":"tao:has_database_id","subj":"194","obj":"MESH:D008107"},{"id":"A195","pred":"tao:has_database_id","subj":"195","obj":"MESH:D003920"},{"id":"A196","pred":"tao:has_database_id","subj":"196","obj":"MESH:D001281"},{"id":"A197","pred":"tao:has_database_id","subj":"197","obj":"MESH:C000657245"},{"id":"A198","pred":"tao:has_database_id","subj":"198","obj":"MESH:C000657245"},{"id":"A199","pred":"tao:has_database_id","subj":"199","obj":"MESH:C000657245"},{"id":"A200","pred":"tao:has_database_id","subj":"200","obj":"MESH:D005334"},{"id":"A201","pred":"tao:has_database_id","subj":"201","obj":"MESH:D003371"},{"id":"A202","pred":"tao:has_database_id","subj":"202","obj":"MESH:D011014"},{"id":"A203","pred":"tao:has_database_id","subj":"203","obj":"MESH:D020521"},{"id":"A204","pred":"tao:has_database_id","subj":"204","obj":"MESH:C000657245"},{"id":"A205","pred":"tao:has_database_id","subj":"205","obj":"MESH:D020521"},{"id":"A206","pred":"tao:has_database_id","subj":"206","obj":"MESH:D000783"},{"id":"A207","pred":"tao:has_database_id","subj":"207","obj":"MESH:D000783"},{"id":"A208","pred":"tao:has_database_id","subj":"208","obj":"MESH:D002532"},{"id":"A209","pred":"tao:has_database_id","subj":"209","obj":"MESH:D002544"},{"id":"A210","pred":"tao:has_database_id","subj":"210","obj":"MESH:D002543"},{"id":"A211","pred":"tao:has_database_id","subj":"211","obj":"MESH:D003643"},{"id":"A219","pred":"tao:has_database_id","subj":"219","obj":"Gene:1401"},{"id":"A220","pred":"tao:has_database_id","subj":"220","obj":"Gene:1401"},{"id":"A221","pred":"tao:has_database_id","subj":"221","obj":"MESH:C000657245"},{"id":"A222","pred":"tao:has_database_id","subj":"222","obj":"MESH:D020246"},{"id":"A224","pred":"tao:has_database_id","subj":"224","obj":"MESH:D020521"},{"id":"A225","pred":"tao:has_database_id","subj":"225","obj":"MESH:D002544"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 1. Demographics, procedure details, outcomes, and laboratory findings\nVariables Mean ± standard deviation; N (%)\nAge (years) 59.5 ± 16.0\nFemale gender 12 (55.5)\nComorbidities\n Hypertension 10 (45.0)\n Chronic heart disease 3 (13.6)\n Chronic lung disease 0 (0.0)\n Chronic kidney disease 1 (4.5)\n Chronic liver disease 0 (0.0)\n Diabetes mellitus 2 (9.1)\n Atrial fibrillation 3 (13.6)\n No comorbidities 12 (54.4)\nCOVID-19 characteristics\n Neurological insult as initial  manifestation of COVID-19 10 (45.5)\n Duration between COVID-19  symptoms and neurological  insults (days) 8.8 ± 4.4\n Fever 11 (50.0)\n Cough 11 (50.0)\n Pneumonia 9 (40.9)\nCerebrovascular insult\n Hemorrhagic stroke 3 (13.6)\n Ischemic stroke 19 (86.4)\nHemorrhagic stroke characteristics and outcomes\n 5.0 mm dissecting PICA aneurysm HH3, flow diversion\n 15 mm PCOM aneurysm HH4, clipped\n 1.4 mm anterior choroidal  artery aneurysm HH1, flow diversion\nIschemic stroke characteristics and outcomes\n Involved vessels 1.4 ± 0.7\n  ICA 3 (15.8)\n  M1 11 (57.9)\n  M2 1 (5.3)\n  Absent LVO 2 (10.5)\n  CVT 2 (10.5)\n NIHSS at admission 13.8 ± 8.0\n Onset to groin access (min) 272.2 ± 169.5\n Mechanical thrombectomy 16 (84.2)\n  General endotracheal anesthesia 13 (81.3)\n  MT technique\n   Contact aspiration 2 (12.5)\n   Stent retriever 1 (6.25)\n   Contact aspiration    + stent retriever 13 (81.3)\n  Procedure duration (min) 42.2 ± 36.3\n  Number of passes 2.1 ± 1.3\n  Rescue stenting 3 (18.8)\n  TICI 2B/3 16 (100)\n Symptomatic intracerebral  hemorrhage 3 (13.6)\nLaboratory findings\n CRP (mg/dl) 20.8 ± 37.9\n D-dimer (ng/dl) 3497.4 ± 6754.3\n Fibrinogen (mg/dl) 329.5 ± 235.4\n Interleukin-6 (pg/dl) 41.6 ± 62.0\nOutcomes at discharge\n mRS 3–6 11 (50)\n Mortality 8 (36.4)\nCOVID-19: coronavirus disease 2019; CRP: C-Reactive Protein; CVT: Cerebral Venous Thrombosis; ICA: Internal Carotid Artery; LVO: Large Vessel Occlusion; MT: mechanical thrombectomy; NIHSS: National Institute of Health Stroke Scale; PCOM: Posterior Cerebral Communicating Artery; PICA: Posterior Inferior Cerebellar Artery; TICI: thrombolysis in cerebral infarction."}